BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16171943)

  • 1. The role of BRCA1 in non-homologous end-joining.
    Bau DT; Mau YC; Shen CY
    Cancer Lett; 2006 Aug; 240(1):1-8. PubMed ID: 16171943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.
    Bau DT; Fu YP; Chen ST; Cheng TC; Yu JC; Wu PE; Shen CY
    Cancer Res; 2004 Jul; 64(14):5013-9. PubMed ID: 15256476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
    Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
    Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
    Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good timing in the cell cycle for precise DNA repair by BRCA1.
    Durant ST; Nickoloff JA
    Cell Cycle; 2005 Sep; 4(9):1216-22. PubMed ID: 16103751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsolved mystery: the role of BRCA1 in DNA end-joining.
    Saha J; Davis AJ
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i18-i24. PubMed ID: 27170701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
    Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
    Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand breaks.
    De la Torre C; Pincheira J; López-Sáez JF
    Histol Histopathol; 2003 Jan; 18(1):225-43. PubMed ID: 12507302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of major defects in non-homologous DNA end joining in human breast cancer cell lines.
    Mérel P; Prieur A; Pfeiffer P; Delattre O
    Oncogene; 2002 Aug; 21(36):5654-9. PubMed ID: 12165865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts.
    Zhong Q; Boyer TG; Chen PL; Lee WH
    Cancer Res; 2002 Jul; 62(14):3966-70. PubMed ID: 12124328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells.
    Thompson EG; Fares H; Dixon K
    Environ Mol Mutagen; 2012 Jan; 53(1):32-43. PubMed ID: 22170030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.
    Tutt A; Ashworth A
    Trends Mol Med; 2002 Dec; 8(12):571-6. PubMed ID: 12470990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DNA repair in the absence of classical non-homologous end joining.
    Kang YJ; Yan CT
    DNA Repair (Amst); 2018 Aug; 68():34-40. PubMed ID: 29929045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks.
    Zhong Q; Chen CF; Chen PL; Lee WH
    J Biol Chem; 2002 Aug; 277(32):28641-7. PubMed ID: 12039951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional deletion of Nbs1 in murine cells reveals its role in branching repair pathways of DNA double-strand breaks.
    Yang YG; Saidi A; Frappart PO; Min W; Barrucand C; Dumon-Jones V; Michelon J; Herceg Z; Wang ZQ
    EMBO J; 2006 Nov; 25(23):5527-38. PubMed ID: 17082765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic exploitation of tumor cell defects in homologous recombination.
    Powell SN; Kachnic LA
    Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
    Dohrn L; Salles D; Siehler SY; Kaufmann J; Wiesmüller L
    Biochem J; 2012 Feb; 441(3):919-26. PubMed ID: 22032289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1.
    Wu G; Jiang X; Lee WH; Chen PL
    Cancer Res; 2003 May; 63(10):2589-95. PubMed ID: 12750284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
    Zhang J; Powell SN
    Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.